QDEL Stock Analysis: Buy, Sell, or Hold?
QDEL - QuidelOrtho Corporation Common Stock
$11.49
0.44 (3.98%)
▲
5d:
+6.69%
30d:
-34.31%
90d:
-51.59%
BUY
HIGH Confidence
Analysis Updated: May 14, 2026 12:00 AM ET
Earnings: May 13, 2026
0d
Smart Money Accumulation
QDEL is down 17.1% this week, but smart money is accumulating calls. Top strike: $15 2026-06-18 with 280 OI. Call ratio: 62% View Scanner →
Strength: 9.7/10
Get Alerted When QDEL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called QDEL this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: QDEL trading at deep discount. Market pricing in -18.2% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: QDEL trading at deep discount. Market pricing in -18.2% annual earnings decline, creating value opportunity for patient investors.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$39.45
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$24.50
53.1% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 8.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: QDEL is currently trading at $11.49, which is considered slightly low relative to its 30-day fair value range of $10.81 to $14.77. From a valuation perspective, the stock is trading at a discount (Forward PE: 4.5) compared to its historical average (8.3). Remarkably, the market is currently pricing in an annual earnings decline of 18.2% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, QDEL is in a strong downtrend. Immediate support is located at $9.92, while resistance sits at $12.85. The stock is showing strong short-term momentum, up 4.0% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $17.30 (+56.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, QDEL is in a strong downtrend. Immediate support is located at $9.92, while resistance sits at $12.85. The stock is showing strong short-term momentum, up 4.0% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $17.30 (+56.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$10.81 -
$14.77
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
84.3%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.0%)
- BULLISH: Trading 56.6% below Wall St target ($17.30)
Trading Range Analysis
30-Day Trading Range
$10.81 -
$14.77
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$9.92
Resistance Level
$12.85
Current Trend
Strong Downtrend
Technical data as of
May 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
4.53
Wall Street Target
$17.30
(+56.6%)
Revenue Growth (YoY)
-10.5%
Earnings Growth (YoY)
-77.1%
Profit Margin
-45.6%
Valuation Discount vs History
-18.2% cheaper
PE vs Historical
4.5 vs 8.3
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-18.2%
(market-implied from PE analysis)
1-Year Target
$9.95
(-10%)
2-Year Target
$8.95
(-19%)
3-Year Target
$8.06
(-27%)
3-Yr Target (if PE normalizes)
(PE: 5→8)
$14.77
(+34%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.0, Growth: 29.3%)
$116.18
(+951%)
Base:
(SPY PE: 4.5, Growth: 29.3%)
$23.86
(+116%)
Bear:
(PE: 3.8, Growth: 29.3%)
$20.28
(+84%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 4.5 to 8.3
Stabilization Target:
$20.26
(+83.4%)
PE Expansion Potential:
+83.4%
Share & Embed Analysis
Last updated: May 14, 2026 2:42 PM ET
Data refreshes hourly during market hours. Next update: 3:42 PM
Data refreshes hourly during market hours. Next update: 3:42 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is QDEL showing a specific setup today?
Insider Activity (6 Months)
7
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Brian J Blaser
BUY
10540 shares
2026-02-13
Joseph M Busky
BUY
3370 shares
2026-02-13
Matthew Strobeck
BUY
10000 shares
2026-02-13
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$85 | 55 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$84 | 60 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$108 | 62 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$119 | 53 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 52 HOLD |
Advanced QDEL Option Strategies
Professional options setups generated by AI based on today's QDEL price and gamma walls.
